Biocon shares may witness some action after the pharma company expanded its generic formulations portfolio, with the launch of tacrolimus capsules in the United States.
from NDTV Profit - Latest https://ift.tt/2WOzU74
via
from NDTV Profit - Latest https://ift.tt/2WOzU74
via
Comments
Post a Comment